WSC 2024 - Visit us!

EVER Pharma will present new data during the symposium on WSC 2024 in Abu Dhabi, UAE. Join this event and get also a lunch package for free!

Cerebroprotection in AIS - New evidence from two different trials

Chair: Steven Zeiler USA

• Add-on therapy following MT in patients with embolic stroke
  Ahmed El Bassiouny (Egypt)
• C-REGS2 – First results of a large high-quality comparative effectiveness study
  Michael Brainin (Austria)

Furthermore we will await you on the booth #15! We are looking forward to you!

Please join also our 'Meet the expert sessions' on our booth:

• 23rd October 2024, 12:10 - 12:25
  Jacek Staszewski
  Can adding a cerebroprotective agent to EVT improve outcome?
• 25th October 2024, 9:40 - 9:55
  Milan Vosko
  Clinical relevance of C-REGS2 study

See you in Abu Dhabi!